Paris, France

Fabrice Agou

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Fabrice Agou in the Fight Against Inflammation and Cancer

Introduction

Fabrice Agou, an accomplished inventor based in Paris, France, holds a remarkable portfolio of 8 patents. His groundbreaking inventions primarily focus on the development of novel therapeutic agents aimed at combating inflammatory conditions and cancer. Agou's work demonstrates a profound commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among his most notable contributions are his latest patents concerning stapled peptide inhibitors of NEMO. These inhibitors target the Nuclear Factor κB (NF-κB) signaling pathway, exhibiting promising potential as candidates for anti-inflammatory and anticancer drugs. This innovative approach could potentially lead to the development of new therapeutic options that address significant health challenges associated with inflammation and cancer.

Career Highlights

Fabrice Agou has made significant strides in the pharmaceutical and biotechnology industries, particularly through his collaborations with prestigious institutions. He has worked at the Institut Pasteur and Les Laboratoires Servier, where he contributed to various research and development initiatives that have advanced scientific knowledge and therapeutic discovery.

Collaborations

Throughout his career, Agou has collaborated with esteemed colleagues, including Francois Traincard and Michel Veron. These partnerships have fostered a creative environment conducive to innovation, allowing for the exploration of new methodologies and solutions to complex biomedical problems.

Conclusion

With a total of 8 patents to his name, Fabrice Agou stands out as a prominent inventor dedicated to advancing medical science. His work on stapled peptide inhibitors of NEMO showcases his innovative spirit and the potential to enhance treatment options for inflammation and cancer. As he continues to push the boundaries of scientific research, Agou remains a key figure in the field of biomedical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…